Cargando…
Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants
The aim of this study was to identify demographic and genetic factors that significantly affect methylphenidate (MPH) pharmacokinetics (PK), and may help explain interindividual variability and further increase the safety of MPH. d‐MPH plasma concentrations, demographic covariates, and carboxylester...
Autores principales: | Lyauk, YK, Stage, C, Bergmann, TK, Ferrero‐Milliani, L, Bjerre, D, Thomsen, R, Dalhoff, KP, Rasmussen, HB, Jürgens, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351003/ https://www.ncbi.nlm.nih.gov/pubmed/27754602 http://dx.doi.org/10.1111/cts.12423 |
Ejemplares similares
-
Regulation of carboxylesterase 1 (CES1) in human adipose tissue
por: Jernås, Margareta, et al.
Publicado: (2009) -
Global inactivation of carboxylesterase 1 (Ces1/Ces1g) protects against atherosclerosis in Ldlr(−/−) mice
por: Xu, Jiesi, et al.
Publicado: (2017) -
Pharmacometabolomics Informs About Pharmacokinetic Profile of Methylphenidate
por: Kaddurah‐Daouk, Rima, et al.
Publicado: (2018) -
Carboxylesterase 1d (Ces1d) does not contribute to cholesteryl ester hydrolysis in the liver
por: Lian, Jihong, et al.
Publicado: (2021) -
Associations between CES1 variants and dosing and adverse effects in children taking methylphenidate
por: Brown, Jacob T., et al.
Publicado: (2023)